Main Street Research’s ResMed RMD Stock Holding History

Main Street Research’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,208	Closed	-$276K	–	120
2024 Q4	$276K	Hold	1,208	–	–	0.02%	95
2024 Q3	$295K	Hold	1,208	–	–	0.02%	86
2024 Q2	$231K	Buy	1,208 +8	+0.7%	+$1.62K	0.02%	91
2024 Q1	$238K	Hold	1,200	–	–	0.02%	93
2023 Q4	$206K	Buy	+1,200	New	+$184K	0.02%	102
2023 Q3	–	Sell	-1,200	Closed	-$262K	–	98
2023 Q2	$262K	Hold	1,200	–	–	0.04%	81
2023 Q1	$263K	Hold	1,200	–	–	0.05%	79
2022 Q4	$250K	Hold	1,200	–	–	0.06%	82
2022 Q3	$262K	Hold	1,200	–	–	0.06%	79
2022 Q2	$252K	Hold	1,200	–	–	0.07%	74
2022 Q1	$291K	Hold	1,200	–	–	0.03%	94
2021 Q4	$313K	Sell	1,200 -19	-2%	-$4.93K	0.02%	102
2021 Q3	$321K	Buy	1,219 +19	+2%	+$5.2K	0.03%	101
2021 Q2	$296K	Hold	1,200	–	–	0.02%	113
2021 Q1	$233K	Sell	1,200 -22	-2%	-$4.41K	0.02%	119
2020 Q4	$260K	Buy	1,222 +22	+2%	+$4.39K	0.03%	104
2020 Q3	$206K	Hold	1,200	–	–	0.03%	109
2020 Q2	$230K	Buy	+1,200	New	+$196K	0.04%	88

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Main Street Research's RMD Position: Q1 2025 in Review

Main Street Research sold out of ResMed (RMD) in Q1 2025, closing a stake of 1,208 shares — an estimated $276K sold.

Main Street Research first reported a position in RMD in Q2 2020 and held it in 18 quarters. The position peaked at $321K in Q3 2021. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

Main Street Research reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
Main Street Research sold 1,208 ResMed shares in Q1 2025, an estimated $276K.
Main Street Research first reported a position in ResMed in Q2 2020 and held it in 18 quarters.
Main Street Research's ResMed position peaked at $321K in Q3 2021.
885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Main Street Research's 13F filing for Q1 2025, filed 30 Apr 2025.